Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers

Affiliations

• ¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
• ² John Hopkins University, Baltimore, USA.
• ³ Weill Cornell Medical College, Division of Rheumatology, Hospital for Special Surgery, New York, USA.
• ⁴ Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, USA.
• ⁵ Université Paris-Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U1184, Le Kremlin Bicêtre, France.
• ⁶ Leiden University Medical Centre, Leiden, The Netherlands.
• ⁷ Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute, Stockholm, Sweden.
• ⁸ UCB Pharma, Brussels, Belgium.
• ⁹ UCB Pharma, Raleigh, USA.
• ¹⁰ Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, USA.